Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) |
|---|---|
| Disease/Condition | Lung Cancer,Oncology (Medical/Hematologic),Lung Diseases,Carcinoma,Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Balazs Halmos, MD |
| Contact Name | Inuska Rodriguez |
| Contact Email | inurodri@montefiore.org |
| Protocol Number | 17-06-456-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Medical and Hematologic Oncology - Lung |
| Adult, Pediatric, Both | Adult |
